10 Research Associates from Elan submitted salaries.
Elan Corp. is a biotechnology company focused on developing pharmaceuticals to treat autoimmune and neurodegenerative disorders. The neuroscience-based company currently markets a multiple sclerosis drug, Tysabri, that it developed in partnership with Biogen Idec. Currently, the company is reportedly working on treatments for ulcerative collitis, Chrohn's disease, Parkinson's disease, bipolar disorder and Alzheimer's disease.
The biotechnology firm is headquartered in Dublin, Ireland. Elan was established in 1969 and converted to a publicly-traded company in 1984. In 2011, Elan merged its drug manufacturing and formulation business, Elan Drug Technologies, with bio-pharmaceutical company Alkermes. Most of Elan's research and development facilities are located in Ireland and the U.S., with offices in South San Francisco, California; Cambridge, Massachusetts and Lucerne, Switzerland.
Elan employs approximately 400 professionals in its several business units: biologics, bioneurology operations, commercial, corporate services, development, neotope, onclave therapeutics and research. Competitive salaries are buoyed by a complete benefits package that includes health, dental, vision and life insurance as well as retirement plans, employee assistance and paid time off. Additional benefits include flexible spending accounts, tuition assistance, an employee stock purchase plan and an employee referral incentive program.
Director of IT is the highest paying job at Elan at 178,000 annually.
Create an account and follow companies, manage job alerts, connect with other professionals and more.
Update your browser to have a more positive job search experience.
Upgrade My Browser